InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: None

Friday, 06/14/2019 12:26:51 AM

Friday, June 14, 2019 12:26:51 AM

Post# of 345960
This pps is behaving like those that had a hand in it for so long are like in a quiet period

Sooner or later it will change and as I see it... as long as the deal is structured with Oncologie I wonder if some BPs will begin to get their foot in the door with Avid before some PS Targeting approval

Trivia question ...how many times did Lisa Stepp visit Hopkinton MA Perkin Elmer site?

.. Cliff Hoyt..an interesting character

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=131555041

I figure some should find it of interest that Cliff ends up with Akoya and Akoya has collaborations with some, including Argonaut where we have Rick Hancock that is Chair of the BOD there....

Mr Hancock certainly aware how big PS Targeting is and the Biomarkers derived out of all work groups





______



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News